Omega Seamaster Gmt Chronometer
CluePoints' solutions are driven by the company's intelligent, patent pending SMART engine that provides customers with the ability to check data quality across all clinical subjects, sites, regions and countries involved in a trial, achieving data consistency, while documenting where and why any anomalies have occurred. Aligned with current FDA and EMA recommendations, the approach ensures that users are able to identify signals in study datasets and can make timely decisions Omega Watch Models
about which sites to target for monitoring activities, resulting in reduced regulatory submission risk and costs.
for clinical trials, has announced a web based version of its intelligent risk based monitoring platform that enables sponsors to determine the quality and integrity of their clinical trial data. The web based CSM software as a service (SaaS) offering will enable customers to control the upload of clinical data for assessment, visualize the findings and interact with analyses to make the understanding of results, comprehension of signals and identification of issues as intuitive as possible. CluePoints will showcase this new platform, alongside the company's portfolio of CSM solutions, on booth 733 during the DIA 2014 Annual Meeting being held from June 15 19, in San Diego, CA.
To offer sponsors and CROs detailed insight into the practical implementation of CSM solutions, a new webinar from CluePoints in collaboration with Sanofi Aventis is now available online, entitled 'Risk Based Monitoring What we've learnt in a year, a Large Pharma Perspective from Sanofi'. The session demonstrates how CSM techniques have been harnessed to improve data quality and oversight, while showcasing the impact that Sanofi has Omega Watch Red
CluePoints To Launch New Web Application For Risk Based Monitoring At Drug Information Associa
Drug Information Association Annual Meeting To Discuss Patient Perspective To Inform Drug Development And Access Tokai Pharmaceuticals Presents New Omega Seamaster Gmt Chronometer Clinical Data For Galeterone Among Patients With Advanced Prostate Cancer At American Society of Clinical Oncology 2014
Pilgrim Software Quality Solutions To Unveil New Branding At 2014 Drug Information Association Annual Meeting NOXXON Pharma AG's Emapticap Pegol Study Selected For Late Breaking Clinical Trials Symposium During ERA EDTA Conference
had on enhancing this technology driven approach. It employs unique statistical algorithms to determine the quality, accuracy and integrity of clinical trial data both during and after study conduct. Aligned with guidance from the FDA and EMA, CluePoints is deployed to support traditional on site monitoring and to drive a risk based monitoring strategy. The value of using CluePoints lies in its powerful and timely ability to identify anomalous data and site errors allowing improvement in clinical data quality, optimization of on site monitoring and a significant reduction in overall regulatory submission risk.
Mission3 To Provide Thought Leadership And Expertise At Drug Information Association 2014 Aduro Biotech Announces American Society of Clinical Oncology Presentation Of Promising Results From Phase 1b Clinical Trial Of Its Novel Immunotherapy For The Treatment Of Mesothelioma
This first version of the web portal aims to put the sponsor in control so that they can run the analysis, set up the SMART engine, construct and manage data within the system, select appropriate statistical tests and perform the complete CSM process independently and objectively. Continuous improvements will be brought to the software to meet clients' needs: a second release will soon support closer to real time assessments of data and generate a customized report whenever required.
PHT Corporation To Sponsor Fundraiser For Rady Children's Hospital San Diego At Drug Information Association Annual Meeting HealthCare Pharmaceuticals Announces American Society of Clinical Oncology Presentation Of DKN 01 Clinical Study In Non Small Cell Lung Cancer And First Patients Dosed In Clinical Study For DKK1+ Esophageal Cancer
Cambridge, MA CluePoints, a leading provider of Centralized Statistical Monitoring (CSM) solutions Omega Speedmaster Racing Review
Drug Information Association Release: Clinical Trial Experts To Discuss Relationship Between "Big Data" And Strategic CRO And Clinical Trial Sponsor Partnerships Tesaro, Inc. (TSRO) Summarizes Phase 3 Rolapitant Data Presented At The 2014 American Society of Clinical Oncology Annual Meeting And Provides An Update On Niraparib Development Strategy
"The launch of CluePoints' web portal marks another exciting industry first for CluePoints as it enables sponsors and contract research organizations (CROs) to drive their own analyses using actual clinical data, rather than just subjective operational metrics, for the first time", comments Fran?ois Torche, CEO of CluePoints. He continues: "We are continually working to enhance the usability of our solutions to meet current industry needs and through discussions with our clients have found that many companies would like to take full control of their risk based monitoring analyses using clinical databases. The new SaaS solution enables them to do this."
Help employers find you! Check out all the .
Omega Seamaster Gmt Chronometer
Omega Seamaster 1960
Copyright 2006–2007 Phoenix Gallery. All rights reserved. Site design by . . . || mccallum design